178 related articles for article (PubMed ID: 16249375)
1. Anti-Epo receptor antibodies do not predict Epo receptor expression.
Elliott S; Busse L; Bass MB; Lu H; Sarosi I; Sinclair AM; Spahr C; Um M; Van G; Begley CG
Blood; 2006 Mar; 107(5):1892-5. PubMed ID: 16249375
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin receptor expression in non-small cell lung carcinoma: a question of antibody specificity.
Brown WM; Maxwell P; Graham AN; Yakkundi A; Dunlop EA; Shi Z; Johnston PG; Lappin TR
Stem Cells; 2007 Mar; 25(3):718-22. PubMed ID: 17110616
[TBL] [Abstract][Full Text] [Related]
3. Identification of a sensitive anti-erythropoietin receptor monoclonal antibody allows detection of low levels of EpoR in cells.
Elliott S; Busse L; McCaffery I; Rossi J; Sinclair A; Spahr C; Swift S; Begley CG
J Immunol Methods; 2010 Jan; 352(1-2):126-39. PubMed ID: 19887071
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin receptors on tumor cells: what do they mean?
Fandrey J
Oncologist; 2008; 13 Suppl 3():16-20. PubMed ID: 18458120
[TBL] [Abstract][Full Text] [Related]
5. Lack of functional erythropoietin receptors of cancer cell lines.
Laugsch M; Metzen E; Svensson T; Depping R; Jelkmann W
Int J Cancer; 2008 Mar; 122(5):1005-11. PubMed ID: 17990315
[TBL] [Abstract][Full Text] [Related]
6. Expression of erythropoietin and erythropoietin receptor in cervical cancer and relationship to survival, hypoxia, and apoptosis.
Leo C; Horn LC; Rauscher C; Hentschel B; Liebmann A; Hildebrandt G; Höckel M
Clin Cancer Res; 2006 Dec; 12(23):6894-900. PubMed ID: 17145806
[TBL] [Abstract][Full Text] [Related]
7. Expression of erythropoietin and its receptor in neuroblastomas.
Sartelet H; Fabre M; Castaing M; Bosq J; Racu I; Lagonotte E; Scott V; Lecluse Y; Barette S; Michiels S; Vassal G
Cancer; 2007 Sep; 110(5):1096-106. PubMed ID: 17647284
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma.
Acs G; Zhang PJ; Rebbeck TR; Acs P; Verma A
Cancer; 2002 Sep; 95(5):969-81. PubMed ID: 12209679
[TBL] [Abstract][Full Text] [Related]
9. Functional and immunochemical characterisation of different antibodies against the erythropoietin receptor.
Kirkeby A; van Beek J; Nielsen J; Leist M; Helboe L
J Neurosci Methods; 2007 Aug; 164(1):50-8. PubMed ID: 17524492
[TBL] [Abstract][Full Text] [Related]
10. Epo receptors are not detectable in primary human tumor tissue samples.
Elliott S; Swift S; Busse L; Scully S; Van G; Rossi J; Johnson C
PLoS One; 2013; 8(7):e68083. PubMed ID: 23861852
[TBL] [Abstract][Full Text] [Related]
11. The functional form of the erythropoietin receptor is a 78-kDa protein: correlation with cell surface expression, endocytosis, and phosphorylation.
Sawyer ST; Hankins WD
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6849-53. PubMed ID: 8341708
[TBL] [Abstract][Full Text] [Related]
12. Expression of erythropoietin and its receptor increases in colonic neoplastic progression: the role of hypoxia in tumorigenesis.
Gombos Z; Danihel L; Repiska V; Acs G; Furth E
Indian J Pathol Microbiol; 2011; 54(2):273-8. PubMed ID: 21623073
[TBL] [Abstract][Full Text] [Related]
13. Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementation.
Maxwell P; Melendez-Rodríguez F; Matchett KB; Aragones J; Ben-Califa N; Jaekel H; Hengst L; Lindner H; Bernardini A; Brockmeier U; Fandrey J; Grunert F; Oster HS; Mittelman M; El-Tanani M; Thiersch M; Schneider Gasser EM; Gassmann M; Dangoor D; Cuthbert RJ; Irvine A; Jordan A; Lappin T; Thompson J; Neumann D
Br J Haematol; 2015 Feb; 168(3):429-42. PubMed ID: 25283956
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression.
Diensthuber M; Ilner T; Rodt T; Samii M; Brandis A; Lenarz T; Stöver T
Otol Neurotol; 2007 Jun; 28(4):559-65. PubMed ID: 17429338
[TBL] [Abstract][Full Text] [Related]
15. Activation of the erythropoietin (EPO) receptor by bivalent anti-EPO receptor antibodies.
Elliott S; Lorenzini T; Yanagihara D; Chang D; Elliott G
J Biol Chem; 1996 Oct; 271(40):24691-7. PubMed ID: 8798737
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin receptor expression and correlation to tamoxifen response and prognosis in breast cancer.
Larsson AM; Jirström K; Fredlund E; Nilsson S; Rydén L; Landberg G; Påhlman S
Clin Cancer Res; 2009 Sep; 15(17):5552-9. PubMed ID: 19706814
[TBL] [Abstract][Full Text] [Related]
17. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts.
Doleschel D; Mundigl O; Wessner A; Gremse F; Bachmann J; Rodriguez A; Klingmüller U; Jarsch M; Kiessling F; Lederle W
J Nucl Med; 2012 Feb; 53(2):304-11. PubMed ID: 22228796
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to erythropoietin receptor in patients with immune-mediated diseases: relationship to anaemia with erythroid hypoplasia.
Hara A; Furuichi K; Higuchi M; Iwata Y; Sakai N; Kaneko S; Wada T
Br J Haematol; 2013 Jan; 160(2):244-50. PubMed ID: 23151030
[TBL] [Abstract][Full Text] [Related]
19. Spatial and Cellular Expression Patterns of Erythropoietin-Receptor and Erythropoietin during a 42-Day Post-Lesional Time Course after Graded Thoracic Spinal Cord Impact Lesions in the Rat.
Cohrs G; Goerden S; Lucius R; Synowitz M; Mehdorn HM; Held-Feindt J; Knerlich-Lukoschus F
J Neurotrauma; 2018 Feb; 35(3):593-607. PubMed ID: 28895456
[TBL] [Abstract][Full Text] [Related]
20. Expression of erythropoietin receptor splice variants in human cancer.
Arcasoy MO; Jiang X; Haroon ZA
Biochem Biophys Res Commun; 2003 Aug; 307(4):999-1007. PubMed ID: 12878211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
